Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Cancer Immunology Research|February 25, 2026
Loss of miR-29a/b1 cluster reprograms the tumor microenvironment and contributes to immunosuppression in lung cancerNatalie K Horvat, Myritney Saint-Cloud, Raihaanah Bint Abdullah Muslim, et al.
Cancer Research|January 6, 2021
Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLCJessica M Konen, B Leticia Rodriguez, Aparna Padhye, et al.
Cell Reports|September 28, 2022
Impad1 and Syt11 work in an epistatic pathway that regulates EMT-mediated vesicular trafficking to drive lung cancer invasion and metastasisRakhee Bajaj, B Leticia Rodriguez, William K Russell, et al.
JCI Insight|July 26, 2021
Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancerAparna Padhye, Jessica M Konen, B Leticia Rodriguez, et al.
Frontiers in Immunology|July 14, 2023
Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistanceB Leticia Rodriguez, Limo Chen, Yanli Li, et al.
Molecular Cancer Research : MCR|November 11, 2020
AXL Inhibition Induces DNA Damage and Replication Stress in Non-Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR InhibitorsKavya Ramkumar, C Allison Stewart, Kasey R Cargill, et al.
Cancer Discovery|February 20, 2019
Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung CancerTriparna Sen, B Leticia Rodriguez, Limo Chen, et al.
Genes & Development|June 2, 2022
The microRNA-183/96/182 cluster inhibits lung cancer progression and metastasis by inducing an interleukin-2-mediated antitumor CD8<sup>+</sup> cytotoxic T-cell responseSamrat T Kundu, B Leticia Rodriguez, Laura A Gibson, et al.
Communications Biology|April 20, 2021
A collagen glucosyltransferase drives lung adenocarcinoma progression in miceHou-Fu Guo, Neus Bota-Rabassedas, Masahiko Terajima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic VulnerabilitiesC Allison Stewart, Lixia Diao, Yuanxin Xi, et al.
Pageof 4